• 1
    Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. N Engl J Med 1999; 341: 427433.
  • 2
    Kopelman PG. Obesity as a medical problem. Nature 2000; 404: 635643.
  • 3
    Haslam DW, James WPT. Obesity. Lancet 2005; 366: 11971209.
  • 4
    Ezzati M, Lopez AD, Rogers A, Vander Hoorn S, Murray CJ. Comparative risk assessment collaborating group. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360: 13471360.
  • 5
    Meigs JB. Metabolic syndrome and risk for type 2 diabetes. Expert Rev Endocrinol Metab 2006; 1: 5766.
  • 6
    Eckel RH, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 14151428.
  • 7
    Grundy SM, Hansen B, Smith SC. Jr, Cleeman JI, Kahn RA. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung and Blood Institute/American Diabetes Association Conference on Scientific Issues Related to Management. Circulation 2004; 109: 551556.
  • 8
    Deckelbaum RJ, Williams CL. Childhood obesity: the health issues. Obes Res 2001; 9(Suppl.): 239S243S.
  • 9
    Lobstein T, Leach R. Diabetes may be undetected in many children in the UK. BMJ 2004; 328: 12611262.
  • 10
    Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin R, Caprio S. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 23622374.
  • 11
    Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, Smith WCS, Jung RT, Campbell MK, Grant AM. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvements. Health Technol Assess 2004; 8: 1182.
  • 12
    Comment: Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157163.
  • 13
    Frohlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, Boeing H, Muche R, Brenner H, Koenig W. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 2000; 23: 18351839.
  • 14
    Timpson NJ, Lawlor DA, Harbord RM, Gaunt TR, Day IN, Palmer LJ, Hattersley A, Ebrahim S, Lowe G, Rumley A. C-reactive protein and its role in metabolic syndrome: mendelian randomization study. Lancet 2005; 366: 19541959.
  • 15
    Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, Tanomsup S, Wangai P Jr, Razak F, Sharma AM, Anand SS. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 366: 16401649.
  • 16
    Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER, Simons-Morton DG, Karanja N, Lin P. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 2001; 344: 310.
  • 17
    Esposito K, Marfella R, Ciotola M, Di Paulo C, Giugliano F, Giugliano G, D’Armiento M, D’Andrea F, Giugliano D. Effect of Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome. A randomized trial. J Am Med Assoc 2004; 292: 14401446.
  • 18
    Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 13431350.
  • 19
    Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Aunola S, Cepaitis Z, Moltchanov V, Hakumaki M, Mannelin M, Martikkala V, Sundvall J, Uusitupa M. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 13431350.
  • 20
    Kesaniemi YA, Danforth E, Jensen MD, Kopelman PG, Lefebvre P, Reeder BA. Dose–response issues concerning physical activity and health: an evidence-based symposium. Med Sci Sports Exerc 2001; 33(Suppl.): S351S358.
  • 21
    Thompson PD, Buchner D, Pina IL, Balady GJ, Williams MA, Marcus BH, Berra K, Blair SN, Costa F, Franklin B, Fletcher GF, Gordon NF, Pate RR, Rodriguez BL, Yancey AK, Wenger NK. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation and Prevention) and the Council on Nutrition, Physical Activity and Metabolism (Subcommittee on Physical activity). Circulation 2003; 107: 31093116.